Reactions Weekly

, Volume 1209, Issue 1, pp 2–2 | Cite as

... and stronger warnings for etoricoxib

Media release
  • 9 Downloads

Keywords

Public Health Hypertension Rheumatoid Arthritis Arthritis Ankylose Spondylitis 

REFERENCE

  1. 1.
    European Medicines Agency (EMEA).EMEA recommends strengthening warnings and contraindications for etoricoxib-containing medicines used in the treatment of rheumatoid arthritis and ankylosing spondylitis. Media Release: 26 Jun 2008. Available from: URL: http://www.emea.europe.eu

Copyright information

© Adis International limited or Adis Data Information BV 2008

Personalised recommendations